tradingkey.logo
tradingkey.logo

Adapthealth Corp

AHCO
11.200USD
-0.210-1.84%
Close 03/27, 16:00ETQuotes delayed by 15 min
350.00MMarket Cap
LossP/E TTM

Adapthealth Corp

11.200
-0.210-1.84%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Adapthealth Corp

Currency: USD Updated: 2026-03-27

Key Insights

Adapthealth Corp's fundamentals are relatively stable, with industry-average ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 20 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 12.88.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Adapthealth Corp's Score

Industry at a Glance

Industry Ranking
20 / 208
Overall Ranking
97 / 4542
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative-

Adapthealth Corp Highlights

StrengthsRisks
AdaptHealth Corp. is a provider of patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home. Its product and service offerings include sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea; medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors and insulin pumps; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. It operates in 50 states through its network of over 670 locations in 47 states.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Undervalued
The company’s latest PE is -21.38, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 140.93M shares, increasing 0.01% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 173.51K shares of this stock.

Analyst Rating

Based on 8 analysts
Buy
Current Rating
12.875
Target Price
+12.84%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Adapthealth Corp is 6.93, ranking 98 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 846.29M, representing a year-over-year decrease of 1.21%, while its net profit experienced a year-over-year decrease of 317.56%.

Score

Industry at a Glance

Previous score
6.93
Change
0

Financials

5.07

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

5.06

Operational Efficiency

8.44

Growth Potential

8.69

Shareholder Returns

7.38

Adapthealth Corp's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Adapthealth Corp is 6.02, ranking 173 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -21.38, which is -334.55% below the recent high of 50.15 and -2.50% above the recent low of -21.92.

Score

Industry at a Glance

Previous score
6.02
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 20/208
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of Adapthealth Corp is 8.00, ranking 61 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 13.00, with a high of 16.00 and a low of 10.50.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 8 analysts
Buy
Current Rating
12.875
Target Price
+12.84%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

115
Total
6
Median
9
Average
Company name
Ratings
Analysts
Adapthealth Corp
AHCO
8
Medtronic PLC
MDT
34
Stryker Corp
SYK
33
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
31
Dexcom Inc
DXCM
31
1
2
3
...
23

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Adapthealth Corp is 9.17, ranking 5 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 12.29 and the support level at 9.57, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
9.38
Change
-0.21

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(3)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
0.325
Buy
RSI(14)
62.360
Neutral
STOCH(KDJ)(9,3,3)
75.647
Neutral
ATR(14)
0.526
High Vlolatility
CCI(14)
97.196
Neutral
Williams %R
25.000
Buy
TRIX(12,20)
0.429
Sell
StochRSI(14)
56.115
Sell
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
11.170
Buy
MA10
10.718
Buy
MA20
10.222
Buy
MA50
10.162
Buy
MA100
10.016
Buy
MA200
9.598
Buy

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Adapthealth Corp is 10.00, ranking 1 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 110.54%, representing a quarter-over-quarter decrease of 5.46%. The largest institutional shareholder is The Vanguard, holding a total of 11.66M shares, representing 8.58% of shares outstanding, with 5.02% decrease in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
One Equity Partners LLC
13.82M
--
BlackRock Institutional Trust Company, N.A.
14.09M
+1.39%
The Vanguard Group, Inc.
Star Investors
11.21M
-4.98%
Deerfield Management Company, L.P.
11.48M
+15.88%
Skyknight Capital, L.P.
8.58M
--
Reinhart Partners, LLC
7.33M
+0.20%
Fidelity Management & Research Company LLC
8.85M
+0.27%
Dimensional Fund Advisors, L.P.
5.98M
+15.65%
State Street Investment Management (US)
4.36M
-0.02%
Segall Bryant & Hamill, LLC
4.30M
-8.19%
1
2

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Adapthealth Corp is 6.49, ranking 58 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.56. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Adapthealth Corp’s latest ESG disclosure is at an average level in the Healthcare Equipment & Supplies industry, showing no material impact on overall risk.

Score

Industry at a Glance

Previous score
6.49
Change
0
Beta vs S&P 500 index
1.45
VaR
+5.03%
240-Day Maximum Drawdown
+17.40%
240-Day Volatility
+47.65%

Return

Best Daily Return
60 days
+10.70%
120 days
+17.38%
5 years
+31.06%
Worst Daily Return
60 days
-13.95%
120 days
-13.95%
5 years
-27.25%
Sharpe Ratio
60 days
+1.01
120 days
+0.94
5 years
-0.03

Risk Assessment

Maximum Drawdown
240 days
+17.40%
3 years
+56.06%
5 years
+78.29%
Return-to-Drawdown Ratio
240 days
+1.69
3 years
+0.03
5 years
-0.15
Skewness
240 days
+0.83
3 years
+1.05
5 years
+0.84

Volatility

Realised Volatility
240 days
+47.65%
5 years
+57.51%
Standardised True Range
240 days
+3.57%
5 years
+5.89%
Downside Risk-Adjusted Return
120 days
+147.27%
240 days
+147.27%
Maximum Daily Upside Volatility
60 days
+39.85%
Maximum Daily Downside Volatility
60 days
+43.52%

Liquidity

Average Turnover Rate
60 days
+0.93%
120 days
+1.06%
5 years
--
Turnover Deviation
20 days
-7.58%
60 days
+1.13%
120 days
+14.89%

Peer Comparison

Healthcare Equipment & Supplies
Adapthealth Corp
Adapthealth Corp
AHCO
7.72 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bioventus Inc
Bioventus Inc
BVS
8.28 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
Anika Therapeutics Inc
ANIK
8.13 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.07 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
Edwards Lifesciences Corp
EW
8.05 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI